S&P Global Equity Method Investments increased by 1.5% to $1.87B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.1%, from $1.80B to $1.87B.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.62B | $1.86B | $1.89B | $1.75B | $1.75B | $1.79B | $1.79B | $1.79B | $1.78B | $1.80B | $1.80B | $1.77B | $1.79B | $1.85B | $1.87B |
| QoQ Change | — | — | +15.0% | +1.6% | -7.3% | -0.1% | +2.4% | -0.1% | -0.2% | -0.7% | +1.1% | +0.3% | -1.4% | +0.6% | +3.4% | +1.5% |
| YoY Change | — | — | — | — | — | +8.3% | -3.6% | -5.2% | +2.0% | +1.4% | +0.2% | +0.5% | -0.7% | +0.6% | +2.8% | +4.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.